Table 2.
Treatment modality- n (%) | |
Adjunctive coils place | 16 (30.1) |
Multiple PED placed | 10 (18.8) |
Follow-up in months (Median; IQR) | 12 (6.0-12.0) |
Latest imaging follow-up data available - n (%) | 51 (96.3) |
Occlusion status at last follow-up - n (%) | |
Completely occluded | 46 (90.2) |
Near completely occluded with neck remnant | 4 (7.8) |
Incompletely occluded | 1 (2.0) |
Latest clinical follow-up data available - n (%) | 53 (100.0) |
Thromboembolic complications - n (%) | 6 (11.3) |
Hemorrhagic complications - n (%) | 2 (3.8) |
Clinical follow-up - n (%) | |
Good (mRS = 0-2) | 49 (92.5) |
Poor (mRS = 3-6) | 4 (7.5) |
Mortality - n (%) | 2 (4.9) |
Overall morbidity - n (%) | 4 (7.5) |
PED, pipeline embolization device; mRS: modified Rankin Scale.